Association of inflammatory factors and aging in Parkinson's disease

Hong Jin,Han-Ying Gu,Cheng-Jie Mao,Jing Chen,Chun-Feng Liu,Han-ying Gu,Cheng-jie Mao,Chun-feng Liu
DOI: https://doi.org/10.1016/j.neulet.2020.135259
IF: 3.197
2020-09-01
Neuroscience Letters
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Parkinson's disease as a common neurodegenerative disease, has been found to be related to inflammation. So we observed the characteristics of inflammatory indexes in patients with Parkinson's disease and investigated the relationship between inflammatory cytokines and clinical characteristics. Emerging data may reveal novel neuroinflammatory pathways and identify new targets for treatment of Parkinson's disease</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We examined the inflammatory indexes in 183 patients and 89 healthy controls in association with clinical characteristics.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Patients had significantly higher levels of monocytes, neutrophils, high-sensitivity C-reactive protein, and monocyte-to-high-density lipoprotein ratios (<em>p</em> &lt; 0.01) and lower levels of lymphocytes (<em>p</em> = 0.02) than the controls. There were no significant differences in age, leukocytes, high-density lipoprotein, or neutrophil-lymphocyte ratios between the two groups (<em>p</em> &gt; 0.05). Multivariate logistic regression analysis of these indicators revealed that lymphocyte level was a protective factor (<em>p</em> = 0.025, OR=-0.679), while high-sensitivity C-reactive protein level was a risk factor (<em>p</em> = 0.000, OR=1.168) for Parkinson's disease. High-sensitivity C-reactive protein levels were higher in older Parkinson's disease patients.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>High-sensitivity C-reactive protein is positively related to the risk of Parkinson's disease, especially in aging patients. High-sensitivity C-reactive protein is a potential biomarker for disease progression and treatment response for Parkinson's disease.</p>
neurosciences
What problem does this paper attempt to address?
The paper attempts to address the issue of exploring the relationship between inflammatory factors and Parkinson's disease (PD), particularly the role of high-sensitivity C-reactive protein (hs-CRP) in Parkinson's disease and its relationship with the age of patients. The study aims to reveal the potential role of inflammatory factors in the pathogenesis of Parkinson's disease and to identify possible biomarkers by comparing inflammatory markers between Parkinson's disease patients and healthy controls, as well as analyzing the levels of inflammatory factors in Parkinson's disease patients of different age groups. This could provide new directions for the diagnosis and treatment of Parkinson's disease. Specifically, the paper focuses on the following aspects: 1. **The relationship between inflammatory factors and Parkinson's disease**: By comparing the inflammatory markers of Parkinson's disease patients and healthy controls, the study explores whether inflammatory factors are related to the occurrence and development of Parkinson's disease. 2. **The role of high-sensitivity C-reactive protein (hs-CRP)**: Special attention is given to the changes in hs-CRP levels in Parkinson's disease patients and its potential as a disease biomarker. 3. **The impact of age factors**: The study analyzes the levels of inflammatory factors in Parkinson's disease patients of different age groups to explore the impact of age on the inflammatory response and how this impact is related to the pathogenesis of Parkinson's disease. Through this research, the paper hopes to provide new ideas and methods for the early diagnosis and treatment of Parkinson's disease.